HomeKOY • FRA
add
Kobayashi Pharmaceutical Co Ltd
Previous close
€30.80
Year range
€27.40 - €35.40
Market cap
445.59B JPY
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Yahoo Finance Australia
1 hour ago
Sharon AI makes $1b NASDAQ debut, secondary listing on the ASX next
4.83%
2.36%
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 53.70B | 5.01% |
Operating expense | 22.50B | 32.08% |
Net income | -3.15B | -166.76% |
Net profit margin | -5.87 | -163.53% |
Earnings per share | — | — |
EBITDA | 5.53B | -43.96% |
Effective tax rate | 42.97% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.61B | 7.41% |
Total assets | 275.33B | 3.75% |
Total liabilities | 64.32B | 23.94% |
Total equity | 211.01B | — |
Shares outstanding | 74.34M | — |
Price to book | 0.01 | — |
Return on assets | 3.12% | — |
Return on capital | 3.94% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.15B | -166.76% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Aug 22, 1919
Website
Employees
3,615
